AU-15330

AU-15330


AU-15330 is a PROTAC degrader targeting the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4. This compound effectively inhibits tumor growth in prostate cancer xenograft models and enhances the efficacy of the AR antagonist enzalutamide. Additionally, AU-15330 demonstrates the ability to induce remission in models of castration-resistant prostate cancer while maintaining a favorable safety profile.

Molecular structure of the compound BP-42279
    • Unit
    • Price
    • Qty
    • 5 MG
    • $350.00
    • 10 MG
    • $640.00
    • 25 MG
    • $1200.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire